Skip to Content

Oncotelic Therapeutics Inc OTLC Stock Quote

| Rating as of


Last close prices updated as of Mar 23, 2023, 3:44 PM EST | USD
  • Last Close 0.055
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.05  –  0.06
  • Year Range 0.04  –  0.25
  • Market Cap 21.5109 Mil
  • Volume / Avg 28,043.0 /  127,088.8
  • Price / Sales 8.47
  • Price / Book 0.89
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis OTLC

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics OTLC

Company Profile OTLC

Business Description

Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer with a focus on rare pediatric cancers, and addressing the current global pandemic. OT-101 is its lead immuno-oncology drug candidate. OT-101 also has activity against SARS-CoV-2. Its other products under pipeline are Artemisinin, CA4P, and Oxi4503. Currently, the company generates revenues from rendering services to other third-party customers for the development of certain drug products or in connection with certain out-licensing agreements.

29397 Agoura Road, Suite 107
Agoura Hills, CA, 91301
Industry Biotechnology
Employees 16

FAQs for Oncotelic Therapeutics Inc Stock

No. OTLC does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

OTLC’s market cap is 21.51 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

OTLC’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare OTLC’s historical performance against its industry peers and the overall market.